Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

2(40.0%)

Phase 2

1(20.0%)

Phase 4

1(20.0%)

Phase 1

1(20.0%)

5Total

N/A(2)

Phase 2(1)

Phase 4(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT07240467Phase 2Not Yet Recruiting

Bovis Calculus Stativus Treat Acute Cerebral Ischemic Stroke With Impaired Consciousness

Role: collaborator

NCT07019012Phase 4Recruiting

Cofrogliptin Once Every 2 Weeks as Add-on Therapy to Metformin and Dapagliflozin Versus Daily Linagliptin in Patients With Type 2 Diabetes.

Role: collaborator

NCT05909098Phase 1Not Yet Recruiting

Safety and Efficacy of Autologous NK Cell Adjuvant Therapy for Relapsed/Refractory Non-Hodgkin's B-cell Lymphoma

Role: lead

NCT05701449Unknown

Prevention and Treatment of Perioperative Lung Injury in Elderly Patients

Role: collaborator

NCT05621473Not ApplicableUnknown

Comparing the Safety and Effectiveness of Tunnel PICC Guided by EDUG and Conventional PICC

Role: collaborator

NCT04996901Completed

The Chinese STEMI PPCI Registry (CSPR)

Role: collaborator

NCT01377766Unknown

The Relationship Between Psychological Factors and Bell's Palsy

Role: collaborator

NCT00685789Not ApplicableCompleted

Acupuncture With Deqi And Psychological Effects in Treatment of Bell's Palsy

Role: collaborator

All 8 trials loaded